Related Experiment Video
Updated: Dec 23, 2025

Author Spotlight: Genetic Profiling for Fluorouracil Response in Gastric Cancer
Published on: May 10, 2024
Association between methylenetetrahydrofolate reductase gene rs1801131 A/C polymorphism and urinary tumors'
Shuaili Xu1, Li Zuo2
1Department of Paediatrics, Changzhou No. 2 People's Hospital Affiliated to Nanjing Medical University, Changzhou, 213003, Jiangsu Province, China.
Background:
The methylenetetrahydrofolate reductase (MTHFR) rs1801131 A/C variant results in a decrease in MTHFR enzymatic activity, which may play an important role in folate metabolism and is also an important source of DNA methylation and DNA synthesis. Several case-control studies have been conducted to assess the association of MTHFR rs1801131 polymorphism with the risk of urinary cancers, yet with conflicting conclusions. To derive a more precise estimation of above relationship, the association between the MTHFR rs1801131 A/C polymorphism and the risk of urinary cancer was performed.
Methods:
A total of 28 case-control studies was identified. The odds ratios (OR) with 95% confidence intervals (CI) was calculated to assess.
Results:
On one hand, we found that the MTHFR rs1801131 A/C polymorphism was associated with increased whole urinary cancers' risk (for example CA vs. AA: OR = 1.12. 95%CI = 1.01-1.24). On the other hand, we found that the MTHFR rs1801131 A/C polymorphism might increase bladder cancer risk both in Asian (C-allele vs. A-allele: OR = 1.35. 95%CI = 1.15-1.60) and African populations (CA vs. AA: OR = 1.63. 95%CI = 1.17-2.25).
Conclusions:
Our current analysis suggested that MTHFR rs1801131 A/C is associated with urinary cancers, especially bladder cancer.
Insights
The methylenetetrahydrofolate reductase (MTHFR) rs1801131 A/C variant is linked to a higher risk of urinary cancers. This genetic polymorphism, affecting folate metabolism, particularly increases the risk for bladder cancer in Asian and African populations.
Area of Science:
- Genetics and Molecular Biology
- Cancer Epidemiology
- Nutritional Biochemistry
Background:
- The methylenetetrahydrofolate reductase (MTHFR) rs1801131 A/C variant impacts MTHFR enzyme activity, crucial for folate metabolism, DNA methylation, and synthesis.
- Previous case-control studies on the association between MTHFR rs1801131 polymorphism and urinary cancer risk have yielded inconsistent results.
Purpose of the Study:
- To conduct a comprehensive analysis to precisely determine the association between the MTHFR rs1801131 A/C polymorphism and the risk of developing urinary cancers.
- To synthesize findings from multiple case-control studies to provide a more robust estimation of the genetic risk.
Main Methods:
- A meta-analysis was performed, aggregating data from 28 relevant case-control studies.
- Statistical analysis involved calculating odds ratios (OR) with 95% confidence intervals (CI) to assess the strength of association.
Main Results:
- The MTHFR rs1801131 A/C polymorphism was found to be associated with an increased overall risk of urinary cancers (OR = 1.12, 95% CI = 1.01-1.24).
- Specifically, this polymorphism was linked to a higher risk of bladder cancer in both Asian populations (C-allele vs. A-allele: OR = 1.35, 95% CI = 1.15-1.60) and African populations (CA vs. AA: OR = 1.63, 95% CI = 1.17-2.25).
Conclusions:
- The MTHFR rs1801131 A/C polymorphism is significantly associated with an elevated risk of urinary cancers.
- The association is particularly pronounced for bladder cancer, highlighting the role of this MTHFR variant in its pathogenesis across different ethnic groups.
Related Concept Videos
Mutagenicity and Carcinogenicity
Cancer Prevention
Some...
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Non-LTR Retrotransposons

